Ngā hua rapu kaituhi :: APM

1

Philadelphia chromosome‐positive acute lymphoblastic leukemia mā Hun Ju Lee, James E. Thompson, Eunice S. Wang, Meir Wetzler

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid Leukemia mā Hun Ju Lee, Naval Daver, Hagop M. Kantarjian, Srđan Verstovšek, Farhad Ravandi

I whakaputaina 2012

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy mā Preetesh Jain, Loretta J. Nastoupil, Jason R. Westin, Hun Ju Lee, Lucy Navsaria, Raphaël Steiner, Sairah Ahmed, Omar Moghrabi, Onyeka Oriabure, Wendy Chen, Maria Badillo, Christopher R. Flowers, Michael Wang

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
4

$Four‐year follow‐up of a single arm, phase <scp>II</scp> clinical trial of ibrutinib with rituximab (<scp>IR</scp>) in patients with relapsed/refractory mantle cell lymphoma (<scp>MCL</scp>)$

Four‐year follow‐up of a single arm, phase <scp>II</scp> clinical trial of ibrutinib with rituximab (<scp>IR</scp>) in patients with relapsed/refractory mantle cell lymphoma (<scp>... mā Preetesh Jain, Jorge Romaguera, Samer A. Srour, Hun Ju Lee, Frederick Hagemeister, Jason R. Westin, Luis Fayad, Felipe Samaniego, Maria Badillo, Liang Zhang, L. Nastoupil, Rashmi Kanagal‐Shamanna, Nathan Fowler, Michael Wang

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma mā Chelsea C. Pinnix, Jillian R. Gunther, Sarah A. Milgrom, R.J. Cruz-Chamorro, L. Jeffrey Medeiros, Joseph D. Khoury, Behrang Amini, Sattva S. Neelapu, Hun Ju Lee, Jason R. Westin, Nathan Fowler, Loretta J. Nastoupil, Bouthaina S. Dabaja

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies mā Miguel Gallardo, Hun Ju Lee, Xiaorui Zhang, Carlos E. Bueso‐Ramos, Laura R. Pageon, Mark J. McArthur, Asha S. Multani, Aziz Nazha, Taghi Manshouri, Jan Parker‐Thornburg, Inmaculada Rapado, Alfonso Quintás‐Cardama, Steven M. Kornblau, Joaquín Martínez‐López, Sean M. Post

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy mā Ajlan Al Zaki, Lei Feng, Grace Watson, Sairah Ahmed, Haleigh Mistry, Loretta J. Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P. Iyer, Hun Ju Lee, Raphaël Steiner, Christopher R. Flowers, Elizabeth J. Shpall, Partow Kebriaei, Sattva S. Neelapu, Jason R. Westin, Paolo Strati

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Management strategies and outcomes for very elderly patients with diffuse large B‐cell lymphoma mā Dai Chihara, Jason R. Westin, Yasuhiro Oki, Mohamed Ahmed, Bryan Do, Luis Fayad, Fredrick B. Hagemeister, Jorge Romaguera, Michelle A. Fanale, Hun Ju Lee, Francesco Turturro, Felipe Samaniego, Sattva S. Neelapu, Maria Alma Rodriguez, Nathan Fowler, Michael Wang, R. Eric Davis, Loretta J. Nastoupil

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

$Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087$

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087 mā Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, Philippe Armand, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Jianxin Lin, Eunhee Kim, Akash Nahar, Arun Balakumaran, Craig H. Moskowitz

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Long‐term survival among 5‐year survivors of adolescent and young adult cancer mā Amy M. Berkman, J. Andrew Livingston, Kelly W. Merriman, Michelle A.T. Hildebrandt, Jian Wang, Seyedeh Dibaj, Jennifer L. McQuade, Nancy You, Anita K. Ying, Carlos H. Bárcenas, Diane C. Bodurka, April DePombo, Hun Ju Lee, John de Groot, Michael Roth

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma mā Paolo Strati, Ankur Varma, Sherry Adkins, Loretta J. Nastoupil, Jason R. Westin, Fredrick B. Hagemeister, Nathan Fowler, Hun Ju Lee, Luis Fayad, Felipe Samaniego, Sairah Ahmed, Yiming Chen, Sandra Horowitz, Sara Arafat, Swapna Johncy, Partow Kebriaei, Victor E. Mulanovich, Ella Ariza‐Heredia, Sattva S. Neelapu

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

$Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma$

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma mā Philippe Armand, Pier Luigi Zinzani, Hun Ju Lee, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Alex F. Herrera, Jianxin Lin, Eunhee Kim, Samhita Chakraborty, Patricia Marinello, Craig H. Moskowitz

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

$Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high‐risk relapsed/refractory Hodgkin lymphoma$

Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high‐risk relapsed/refractory Hodgkin lymphoma mā Matthew Mei, Joycelynne Palmer, Hun Ju Lee, Iris Isufi, Robert Chen, Ni‐Chun Tsai, Saro H. Armenian, James L. Godfrey, Joo Y. Song, John H. Baird, Swetha Kambhampati, Yazeed Samara, Jessica Flores, Lacolle Peters, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Alex F. Herrera

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

$Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma$

Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma mā Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Paolo Strati, Penny Fang, Misha Hawkins, Sherry Adkins, Jason R. Westin, Sairah Ahmed, Luis Fayad, Hun Ju Lee, Ranjit Nair, Raphaël Steiner, Swaminathan P. Iyer, Maria Alma Rodriguez, Michael Wang, Christopher R. Flowers, Sattva S. Neelapu, Loretta J. Nastoupil

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Low 25(OH) vitamin D<sub>3</sub> levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia mā Hun Ju Lee, Josephia R. Muindi, Wei Phin Tan, Qiang Hu, Dan Wang, Song Liu, Gregory E. Wilding, Laurie Ford, Sheila N.J. Sait, AnneMarie W. Block, Araba A. Adjei, Maurice Barcos, Elizabeth A. Griffiths, James E. Thompson, Eunice S. Wang, Candace S. Johnson, Donald L. Trump, Meir Wetzler

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Pre‐treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma mā Jay P. Reddy, Mike Hernández, Jillian R. Gunther, Bouthaina S. Dabaja, Geoffrey V. Martin, Wen Jiang, Mani Akhtari, Pamela K. Allen, Bradley J. Atkinson, Grace L. Smith, Chelsea C. Pinnix, Sarah A. Milgrom, Zeinab Abou Yehia, E.M. Osborne, Yasuhiro Oki, Hun Ju Lee, Fredrick B. Hagemeister, Michelle A. Fanale

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study mā Radhakrishnan Ramchandren, Eva Domingo‐Domènech, Antonio Rueda, Marek Trněný, Tatyana Feldman, Hun Ju Lee, Mariano Provencio, Christian Sillaber, Jonathon B. Cohen, Kerry J. Savage, Wolfgang Willenbacher, Azra H. Ligon, Jing Ouyang, Robert Redd, Scott J. Rodig, Margaret A. Shipp, Mariana Sacchi, Anne Sumbul, Philippe Armand, Stephen M. Ansell

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

$The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma$

The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma mā Dai Chihara, Michelle A. Fanale, Roberto N. Miranda, Mansoor Noorani, Jason R. Westin, Loretta J. Nastoupil, Fredrick B. Hagemeister, Luis Fayad, Jorge Romaguera, Felipe Samaniego, Francesco Turturro, Hun Ju Lee, Sattva S. Neelapu, Maria Alma Rodriguez, Michael Wang, Nathan Fowler, R. Eric Davis, L. Jeffrey Medeiros, Chitra Hosing, Yago Nieto, Yasuhiro Oki

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma mā Chelsea C. Pinnix, Bouthaina S. Dabaja, Sarah A. Milgrom, Grace L. Smith, Zeinab Abou, Loretta J. Nastoupil, Jorge Romaguera, Francesco Turturro, Nathan Fowler, Luis Fayad, Jason R. Westin, Sattva S. Neelapu, Michelle A. Fanale, Maria Alma Rodriguez, Frederick Hagemeister, Hun Ju Lee, Yasuhiro Oki, Michael Wang, Felipe Samaniego, Linda Chi, Bita Esmaeli

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

$A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma$

A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma mā Sarah A. Milgrom, Hesham Elhalawani, Joonsang Lee, Qianghu Wang, Abdallah Mohamed, Bouthaina S. Dabaja, Chelsea C. Pinnix, Jillian R. Gunther, Laurence E. Court, Arvind Rao, Clifton D. Fuller, Mani Akhtari, Michalis Aristophanous, Osama Mawlawi, Hubert H. Chuang, Erik P. Sulman, Hun Ju Lee, Frederick Hagemeister, Yasuhiro Oki, Michelle A. Fanale, Grace L. Smith

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: